Over the five years to 2015, industry revenue for the Medical Research industry is expected to grow at an annualized rate of 10.0% to total $9.2 billion. In 2015 alone, revenue is anticipated to increase 8.6%. Over the period, revenue growth has been steadily slowing; the industry is beginning to mature and competition for government funds and private funds has increased. Over half of industry revenue is derived from government funding.
The Medical Research industry comprises two major types of institutions: biotechnology companies and medical research institutions.
The Medical Research industry in China is engaged in basic and applied research and development in the medical and pharmaceutical fields. Enterprises include laboratories of medical research institutes, medical schools and biotech firms. The following research functions are not included in the industry: R&D activities by pharmaceutical or medical equipment manufacturing industries; research unrelated to the human body or human diseases; and the commercialization of medical research.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.